Originally published by our sister publication Pharmacy Practice News
By PPN StaffThe FDA approved mirikizumab-mrkz (Omvoh, Eli Lilly) infusion for the treatment of moderately to severely active ulcerative colitis (UC) in adults.
OCTOBER 27, 2023
Originally published by our sister publication Pharmacy Practice News
By PPN StaffThe FDA approved mirikizumab-mrkz (Omvoh, Eli Lilly) infusion for the treatment of moderately to severely active ulcerative colitis (UC) in adults.